# Knee OA Independent Multi-Axis Review Packet v1

> **Review target:** functional synthetic Knee-OA Physio Referral candidate  
> **Pinned accepted candidate head:** `6539351c592c1dc3e49931057b63925dea3cb94d`  
> **Tested substantive implementation head:** `243095ca9545bd2f96be8986520aeae8c3551c27`  
> **Product-owner acceptance:** design / functional direction accepted for review progression  
> **Independent review status:** NOT YET PERFORMED  
> **Release authority:** NONE

## 1. Purpose

Review whether this single-diagnosis Knee-OA vertical slice is clinically credible, physiotherapy-useful, cognitively light, accessible enough to continue, and commercially capable of justifying recurring subscription value before adding a second diagnosis.

This packet deliberately does **not** ask the reviewer to validate the author's prior conclusions. The reviewer should assume that any design or clinical choice may be wrong until independently checked.

## 2. Exact candidate to inspect

Primary functional surface:

```text
clinic_utilities/physio_referral_product/prototype/index.html
clinic_utilities/physio_referral_product/prototype/app.js
clinic_utilities/physio_referral_product/prototype/qualifiers.js
clinic_utilities/physio_referral_product/prototype/qualifier_overlay.py
clinic_utilities/physio_referral_product/prototype/server.py
clinic_utilities/physio_referral_product/prototype/styles.css
```

Clinical/evidence design:

```text
clinic_utilities/physio_referral_product/contracts/knee_oa_evidence_contract_v1.yaml
clinic_utilities/physio_referral_product/contracts/knee_oa_template_contract_v1.yaml
clinic_utilities/physio_referral_product/contracts/knee_oa_evidence_interaction_v1.yaml
clinic_utilities/physio_referral_product/KNEE_OA_EVIDENCE_DESIGN_V1.md
clinic_utilities/physio_referral_product/UX_CONTRACT_CURRENT.md
```

Tested refinement record:

```text
clinic_utilities/physio_referral_product/KNEE_OA_STEP6A_QUALIFIER_REFINEMENT_RESULT.md
```

Technical acceptance evidence:

```text
GitHub Actions run 34627436841 — SUCCESS
15 / 15 existing real-CU1/HTTP tests
8 / 8 qualifier projection tests
15 frozen exact Greek-output fixtures
12 / 12 existing Chromium tests
6 / 6 qualifier Chromium tests
packaged dependency closure PASS
```

These tests are engineering evidence, not clinical validation.

## 3. Current intended product behavior

Routine surface should remain small. Clinical depth appears progressively:

```text
broad first tap
→ clinically meaningful qualifier only when relevant
→ completed detail collapses into compact clinical summary
```

Examples:

```text
Πόνος
  → Έσω μεσάρθρια · Χήνειος πόδας

Δυσκαμψία
  → Πρωινή ≤30′ · μετά ακινησία

Αδυναμία
  → Τετρακέφαλος · ατροφία
```

Power-user examination details remain under `Περισσότερα`.

The prototype uses a real inherited CU-1 validation/safety engine, but remains synthetic-only and loopback-only.

## 4. Clinical/evidence review questions

Independently inspect whether:

1. Knee-OA phenotype capture is clinically meaningful without pretending to perform a full diagnostic workup.
2. Pain-location choices are appropriate for a Knee-OA referral workflow.
3. Pes-anserine pain/tenderness is correctly represented as location/finding rather than automatically diagnosed bursitis.
4. Generic weakness, objective weakness, quadriceps weakness and visible atrophy remain semantically distinct.
5. Stiffness is correctly separated from measured ROM / fixed flexion deformity.
6. Morning stiffness `>30′` is handled with appropriate caution and without unjustified inference.
7. Fixed flexion deformity, extension lag, effusion and focal tenderness are useful and placed at the right UI depth.
8. The three default rehabilitation components are justified as defaults.
9. Suggestions are truly suggestions rather than hidden treatment selection.
10. Evidence states distinguish support, conditional use, insufficient evidence, guideline disagreement and recommendation against without false precision.
11. Evidence strength is not incorrectly inherited from broad recommendations to narrower product-specific actions.
12. No intervention is presented more positively or negatively than current authoritative guidance supports.
13. Important Knee-OA evidence or safety information is materially missing.
14. Source-to-claim traceability is sufficient for a clinician-facing paid product.
15. Any exact source year, strength, scope or review-date wording is misleading.

For every material evidence claim, classify:

```text
SUPPORTED
PARTIALLY SUPPORTED / OVERSTATED
CONFLICTING GUIDANCE
INSUFFICIENT EVIDENCE
UNVERIFIED
INCORRECT
```

Do not convert `insufficient evidence` into `ineffective`.

## 5. Physiotherapy usefulness review questions

Assess from the receiving physiotherapist's perspective:

1. Does the referral communicate useful diagnosis, impairment and functional context?
2. Does it improve over a generic “please provide physiotherapy” referral?
3. Is it too prescriptive about techniques or exercise details?
4. Does it preserve physiotherapist professional autonomy?
5. Are findings such as quadriceps weakness, atrophy, FFD, effusion and functional limitations clinically actionable?
6. Are any included findings noise rather than useful handoff information?
7. Is any key information missing that would materially improve triage or treatment planning?
8. Does the referral distinguish physician findings from treatment suggestions clearly enough?
9. Is copied Greek prose natural and clinically usable?
10. What should be removed to make the referral better?

## 6. UX / accessibility review questions

Assess the actual workflow rather than the conceptual architecture:

1. Can the common referral be completed rapidly without learning the interface?
2. Does progressive disclosure reduce cognitive load or simply hide complexity?
3. Are qualifiers discoverable without explanatory labels such as `Why?` or `Advanced settings`?
4. Is it always clear what is selected versus what evidence supports?
5. Are evidence colours understandable with the non-colour cue?
6. Is `Περισσότερα` sufficiently discoverable for power users?
7. Do compact summaries make the screen feel like a clinical picture rather than a form?
8. Are suggestions useful or distracting?
9. Is the `i` interaction sufficient to establish trust without PubMed overload?
10. Is `Έτοιμη · 1 σημείο για έλεγχο` appropriately calm and understandable?
11. Are there unnecessary taps or hidden state risks?
12. Are touch targets, reflow, focus order, modal behavior and forced-colour behavior plausible for production progression?
13. What requires real Safari / VoiceOver testing before release?
14. What UI element should be removed first if the product feels busy?

## 7. Commercial review questions

Assume an initial proposed price around **€9.99/month or €99/year** and a target of roughly 100 paying clinicians rather than venture-scale growth.

Assess:

1. Is the recurring value materially greater than a static referral template?
2. Is evidence maintenance/update visibility strong enough to justify subscription rather than one-time purchase?
3. What is the strongest reason a doctor would pay?
4. What is the strongest reason a doctor would cancel after one month?
5. Which feature currently contributes most to retention?
6. Which feature looks impressive but adds little willingness to pay?
7. Does the product solve a frequent enough workflow to create habit?
8. Is the evidence layer a differentiator or merely decoration?
9. Is the product too narrow at Knee OA only for actual purchase, even if Knee OA is correct for validation?
10. What minimum expansion would be needed before charging, without building a full Clinical Cockpit?
11. Does €9.99 feel too high, appropriate or too low for the reviewed experience?
12. What single change would most improve conversion?
13. What single change would most improve retention?

Do not recommend tier proliferation unless there is a concrete need.

## 8. Required scoring

Score each domain from 1–5, but narrative findings outrank scores:

```text
Clinical correctness / evidence fidelity
Safety / non-misleading behavior
Physiotherapy usefulness
Professional autonomy preservation
Routine speed
Cognitive load
Discoverability
Evidence transparency / trust
Accessibility readiness
Referral prose quality
Differentiation
Recurring value
Likely willingness to pay at €9.99
```

For each score provide one sentence explaining what prevents a higher score.

## 9. Finding severity

Every finding must be classified:

```text
BLOCKER
MATERIAL BEFORE SECOND DIAGNOSIS
MATERIAL BEFORE COMMERCIAL PILOT
IMPROVEMENT
LATER / OPTIONAL
```

A reviewer should avoid recommending implementation merely because an idea is clinically interesting.

## 10. Mandatory removal question

The reviewer must answer:

> **If forced to simplify the product by 20%, what would you remove first and why?**

This question is mandatory because the primary product risk is feature accumulation destroying the low-friction workflow.

## 11. Required final verdict

Return exactly one:

```text
REVIEW PASS — no material blocker; proceed to bounded refinement/release planning
CONDITIONAL PASS — promising but material findings must be corrected before expansion
REVIEW HOLD — one or more blockers make expansion premature
```

Then state:

```text
MATERIAL OPEN FINDINGS: <number>
BLOCKERS: <number>
TOP 3 CORRECTIONS: ...
TOP 3 THINGS NOT TO CHANGE: ...
```

## 12. Important limitations known before review

The reviewer must not treat these as hidden defects, but may judge whether they are acceptable at this stage:

- synthetic-only / no real-patient use;
- no production integration or public hosting;
- actual iPhone Safari / VoiceOver not yet tested;
- complete measured accessibility/contrast audit not yet performed;
- source links are largely source-level rather than exact recommendation/page locators;
- independent source-to-claim audit has not yet been completed;
- commercial willingness-to-pay has not been tested with paying users;
- one diagnosis only by deliberate design.

The reviewer remains free to conclude that any of these should become a blocker before the next product stage.
